3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
2
Completed
2
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
2
Breast Neoplasms
2
Primary Ovarian Insufficiency
1
Pediatric Solid Tumor
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Leukemia, Eosinophilic, Acute
1
Leukemia, Basophilic, Acute
1
Leukemia
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Hematopoietic and Lymphoid System Neoplasm
1
Endometrial Neoplasms
1
Congenital Abnormalities
1
Breast Screening
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
pembrolizumab
15
Paclitaxel
15
Carboplatin
13
Specimen Handling
6
Biopsy
6
durvalumab
5
Magnetic Resonance Spectroscopy
5
dostarlimab
4
Taxes
4
Surveys and Questionnaires
4
Observation
4
Letrozole
4
Everolimus
4
Cisplatin
4
olaparib
3
lenvatinib
3
ceralasertib
3
Doxorubicin
3
sacituzumab govitecan
2
pertuzumab
2
copanlisib
2
cabozantinib
2
atezolizumab
2
abemaciclib
2
Trastuzumab
2
Robotic Surgical Procedures
2
Pemetrexed
2
Nivolumab
2
Metformin
2
Megestrol Acetate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Endometrial Neoplasms
×
Genetic Testing
×
Clear all
NCT05591131
2025-02-21
GTM-I
Augusta University
Phase NA
Active not recruiting
21 enrolled